A new experimental treatment for Melanoma, one of the deadliest variants of skin cancer, could be available in a matter of years. At the helm of the project is Moderna, a Cambridge-based biotech company well-known for its Covid-19 vaccine. The vaccine, known as mRNA-4157, is created using Moderna’s mRNA technology to develop a custom-built vaccine […]